List of products


1108 Embassy Centre , Nariman Point, Mumbai 400 021, India. Website:
Email:
ENTIRE PRODUCT LIST
Name of the Product
Composition
SUPPOSITORIES AND PESSARIES:
Bottle 10s/ Strip (5s)
Bottle (10s) / Strip (5s) Bisacodyl B.P. 5 mg
Bottle (10s) / Strip (5s) Bisacodyl B.P. 10 mg
Metronidazole Suppositories B.P. 1000 mg Metoclopramide Hcl U.S.P. = Metoclopramide 20 mg (Adult) Metoclopramide Hcl U.S.P. = Metoclopramide 20 mg (Infant) Lidocaine B.P. 3.00% w/w Zinc Oxide B.P. 5.00% w/w Allantoin B.P. 0.50% w/w Bismuth Oxide 24 mg Zinc Oxide USP 296 mg Peru Balsam BPC 49 mg Paracetamol & Promethazine Suppositories Paracetamol & Promethazine Suppositories EXTERNAL LIQUID:
Xylometazoline Hydrochloride I.P. 0.1% w/v Benzalkonium Chloride Solution IP 3% v/v Benzalkonium Chloride Solution IP 3% v/v Composition: (w/v) Camphor IP 10 %, Thymol IP 1.25 %, Menthol IP 25 %, Cinnamon oil BP 4.2 %, Terpineol BP 12.5 %, Pine oil BPC 21%, Eucalyptus oil IP 21 % w/v TABLETS:
Theophylline (hydrated) I.P 198 mg Ephedrine HCL I.P. 48 mg Calcium Carbonate & Vitamin D3 Tablets Calcium Carbonate 625mg (Oyster Shell), equivalent to 250 mg. elemental Calcium. Vitamin D3 I.P. 125 I.U. Calcium Carbonate & Vitamin D3 Tablets Calcium Carbonate 1250 mg (Oyster Shell) equivalent to 500 mg. elemental Calcium. Vitamin D3 I.P. 250 I.U. Each dual coated tablet contains: Outer layer (Sugar coated for gastric release) Simethicone I.P. 80 mg Inner layer (Enteric coated for intestinal release)Activated Charcoal I.P. 250 mg Each uncoated tablet contains: Paracetamol I.P 500 mg Diclofenac Sodium I.P. 50 mg (Enteric Coated) Each film coated tablet contains: Roxithromycin B.P. 150 mg Each film coated tablet contains: Ferrous Fumarate I.P. 150 mg, Folic Acid I.P 750 mcg, Zinc Sulphate Monohydrate USP 61.8 mg equivalent to Elemental Zinc 22.5 mg Cyanocobalamin IP 7.5 mcg. Each enteric coated tablet contains: Pantoprazole Sodium sesquihydrate Equivalent to Pantoprazole 20 mg Each film coated tablet contains: Calcium carbonate IP 1000 mg, Magnesium Hydroxide IP 240 mg, Zinc Sulphate Monohydrate USP 11 mg, Vitamin D3 IP 200 IU Cefpodoxime Proxetil Dispersible Tablets Each uncoated dispersible tablet contains: Cefpodoxime Proxetil IP = Cefpodoxime 50 mg Cefpodoxime Proxetil Dispersible Tablets Each uncoated dispersible tablet contains: Cefpodoxime Proxetil IP = Cefpodoxime 100 mg Cefpodoxime Proxetil IP = Cefpodoxime 200 mg DRY SYRUP:
LIQUID ORALS:
Each ml. Contains: Simethicone Emulsion USP equivalent Simethicone USP 40 mg, Dill Oil BP 0.005 ml. Fennel Oil 0.0007 ml, Syrupy base q.s. Each 5 ml. Contains: Bromhexine HCl IP 04 mg. Dextromethorphan HBr IP 05 mg. Flavoured Sugar free base q.s. Each 5 ml. of suspension contains: 625mg Calcium Carbonate from organic source (Oyster Shell ) equivalent to elemental Calcium 250 mg, L- Lysine Monohydrochloride USP 50 mg., Zinc Gluconate USP 38.33 mg. equivalent to elemental Zinc 5 mg., Vitamin D3 I.P.125 I.U. Each 5 ml contains: Ambroxol Hydrochloride IP 15 mg. Terbutaline Sulphate IP 1.25 mg. Guaiphenesin IP 50 mg. Menthol IP 0.5 mg. Flavoured sugar free base q.s. AYURVEDIC PRODUCTS:
Sonamukhi 34 % , Saunf 21% w/w, Harde 17 %, Kalimiri 11 %, Saindhav 3 %, Sanchal 4 %, Sonageru 7 %, Sajikhar 3 % Each Lozenges contains: Yashtimadhu Extract 70 mg, Lavang 5mg, Haldi 5mg, Sunth 20 mg, Elaichi 18mg, Khadir 120mg, Dalchini 40 mg, Excipients q.s.

Source: http://www.meridianentp.com/view-entire-product-list.pdf

Powerpoint presentation

Prescription Drug Coverage and Drug Utilization: Evidence from the Medicare Part D Expansion Prescription Drug Coverage and Drug Utilization Background • Optimal design of prescription drug insurance involves a tradeoff » Financial and health benefits of insurance versus » Costs of insurance from moral hazard» Better consumption smoothing » Relaxation of financial constraints

Publikationsliste_kaschabek

Dr. Stefan Kaschabek Technische Universität Bergakademie Freiberg Technische Universität Bergakademie Freiberg Interdisziplinäres Ökologisches Zentrum IÖZ Interdisciplinary Environmental Research Centre (2) Vorträge, Abstracts, Beiträge / Talks, Abstracts, contributions (1) Publikationen / Publications Frank N, Lissner A, Winkelmann M, Hüttl R, Mertens F, Kaschabek SR , Sc

Copyright © 2010-2014 Drug Shortages pdf